Safety and Effectiveness of Cell Therapy in Neurodegenerative Diseases: Take-Home Messages From a Pilot Feasibility Phase I Study of Progressive Supranuclear Palsy

Mesenchymal stromal cells (MSCs) are multipotent cells with anti-inflammatory properties. Here we tested the safety of MSCs in patients with progressive supranuclear palsy (PSP; ClinicalTrials.gov: NCT01824121; Eudract No. 2011-004051-39). Seven patients were treated. To improve the safety, protocol...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Rosaria Giordano, Margherita Canesi, Maurizio Isalberti, Giovanni Marfia, Rolando Campanella, Daniele Vincenti, Viviana Cereda, Alessandra Ranghetti, Chiara Palmisano, Ioannis Ugo Isaias, Riccardo Benti, Giorgio Marotta, Lorenza Lazzari, Tiziana Montemurro, Mariele Viganò, Silvia Budelli, Elisa Montelatici, Cristiana Lavazza, Araceli Rivera-Ordaz, Gianni Pezzoli
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2021-10-01
coleção:	Frontiers in Neuroscience
Assuntos:	progressive supranuclear palsy (PSP) Parkinson’s disease cell therapy mesenchymal stromal cells (MSCs) posture
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fnins.2021.723227/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!